Rheumatic fever presentation and outcome: A case-series report

Revista Brasileira de Reumatologia

Volumn 52, Issue 2, 2012, Pages 236-243

  de Carvalho, Simone Manso ^a   Dalben, Ivete ^a   Corrente, José Eduardo ^a   Magalhães, Claudia Saad ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Arthritis; Chorea; Outcome assessment (health care); Rheumatic fever

Indexed keywords

ANTISTREPTOLYSIN; PENICILLIN G;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CARDITIS; CASE STUDY; CHILD; CHOREA; CLINICAL FEATURE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; ERYTHEMA; ERYTHEMA MARGINATUM; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYARTHRITIS; PROBABILITY; RELAPSE; RETROSPECTIVE STUDY; RHEUMATIC FEVER; SEX DIFFERENCE; SUBCUTANEOUS NODULE; SURVIVAL; TREATMENT OUTCOME; RECURRENT DISEASE;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RHEUMATIC FEVER;

EID: 84859362127     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366(9480):155-168.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal disease. Lancet Infect Dis 2005; 5(11):685-694.
3. Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr 2006; 17(4):164-165.
4. Ferrieri P; Jones Criteria Working Group. Proceedings of the Jones Criteria workshop. Circulation 2002; 106(19):2521-2523.
5. World Health Organization. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators. Bull World Health Organ 1992; 70(2):213-218.
6. World Health Organization expert consultation on rheumatic fever and rheumatic heart disease (2001: Geneva Switzerland). Rheumatic fever and rheumatic heart disease: Report of a WHO expert consultation, Geneva, 29 October-1 November 2001. Geneva: World Health Organization Bulletin (2004).
7. Barbosa PJB, Müller RE, Latado AL, Achutti AC, Ramos AIO, Weksler C et al. Diretrizes brasileiras para diagnóstico, tratamento e prevenção da febre reumática da Sociedade Brasileira de Cardiologia, da Sociedade Brasileira de Pediatria e da Sociedade Brasileira de Reumatologia. Arq Bras Cardiol 2009; 93:1-18.
8. Stewart T, McDonald R, Currie B. Acute rheumatic fever: adherence to secondary prophylaxis and follow-up of Indigenous patients in the Katherine region of the Northern Territory. Aust J Rural Health 2007; 15(4):234-240.
9. Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilário MO. Resource utilization and cost of rheumatic fever. J Rheumatol 2001; 28(6):1394-1397.
10. Peacock J, Kerry S. Presenting medical statistics: from proposal to publication. Oxford University Press, 2006; p.135-149.
11. da Silva CH and Pediatric Committee - São Paulo Pediatric Society. Rheumatic fever: a multicenter study in the state of São Paulo. Rev Hosp Clin Fac Med Sao Paulo 1999; 54(3):85-90.
12. Bitar FF, Hayek P, Obeid M, Gharzeddine W, Mikati M, Dbaibo GS. Rheumatic fever in children: A 15-year experience in a developing country. Pediatr Cardiol 2000; 21(2):119-122.
13. Ravisha MS, Tullu MS, Kamat JR. Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch Med Res 2003; 34(5):382-387.
14. Borges F, Barbosa ML, Borges RB, Pinheiro OC, Cardoso C, Bastos C et al. Características clínicas e demográficas em 99 episódios de febre reumática no Acre, Amazônia Brasileira. Arq Bras Cardiol 2005; 84(2):111-114.
15. Terreri MT, Caldas AM, Len C, Ultchak F, Hilário MOE. Clinical and demographic features of 193 patients with rheumatic fever. Rev Bras Reumatol 2006; 46(6):385-390.
16. Olgunturk R, Canter B, Tunaoglu FS, Kula S. Review of 609 patients with rheumatic fever in terms of revised and updated Jones criteria. Int J Cardiol 2006; 112(1):91-98.
17. Carceller A, Tapiero B, Rubin E, Miró J. Acute rheumatic fever: 27 year experience from Montreal's pediatric tertiary care centers. Ann Pediatr (Barc) 2007; 67(1):5-10.
18. Pileggi GC, Ferriani VP. Manifestações atípicas em crianças com febre reumática. J Pediatr (Rio J) 2000; 76(1):49-54.
19. Hilário MO, Terreri MT. Rheumatic fever and post-streptococcal arthritis. Best Pract Res Clin Rheumatol 2002; 16(3):481-494.
20. Van der Helm-van Mil AH. Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered. Curr Opin Rheumatol 2010; 22(4):437-442.
21. Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart.2005; 91(8):1019-1022.
22. Terreri MT, Roja SC, Len CA, Faustino PC, Roberto AM, Hilário MO. Sydenham's chorea - clinical and evolutive characteristics. Sao Paulo Med J 2002; 120(1):16-19.
23. Cavalcanti A, Hilário MO, Santos FH, Bolognani SA, Bueno OF, Len CA. Subtle cognitive deficits in adults with a previous history of Sydenham's chorea during childhood. Arthritis Care Res (Hoboken) 2010; 62(8):1065-1071.
24. Costa LP, Domiciano DS, Pereira RMR. Características demográficas, clínicas, laboratoriais e radiológicas da febre reumática: revisão sistemática. Rev Bras Reumatol 2009; 49(5):606-616.
25. Machado CS, Ortiz K, Martins Ade L, Martins RS, Machado NC. Antistreptolysin O titer profile in acute rheumatic fever diagnosis. J Pediatr (Rio J) 2001; 77(2):105-111.
26. Pelajo C, Lopez-Benitez JM, Torres JM, Oliveira SKF. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatric Rheumatology 2010; 8:22. Available from: http://www.ped-rheum.com/content/pdf/1546-0096-8-22.pdf. [Accessed on 24 August 2011].